Tashinone II A-sulfoacid-natrum elevates the pain threshold through inhibiting nuclear factor kappa B pathway in neuropathic cancer pain.

Journal: Indian journal of cancer
PMID:

Abstract

OBJECTIVE: The purpose of this study was to evaluate the effects of Tashinone II A-sulfoacid-natrum on the pain threshold and potential molecular mechanism for neuropathic cancer pain.

Authors

  • T Jian-Min
    Department of Anesthesiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, PR China.
  • L Jun
    Department of Anesthesiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, PR China.
  • C Sheng-Yang
    Department of Anesthesiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, PR China.
  • Y Shuang-Mei
    Department of Anesthesiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, PR China.
  • C Shu-E
    Department of Anesthesiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, PR China.
  • Y Xiu-Qin
    Department of Anesthesiology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, PR China.
  • P Chen
    Department of Pharmacy, The People's Hospital of Lishui City, Lishui, Zhejiang, PR China.
  • Z Ling-Bin
    Department of Anesthesiology, The People's Hospital of Lishui City, Lishui, Zhejiang, PR China.